Health
Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302 JAK Inhibitor for Ulcerative Colitis and Crohn's Disease
SHANGHAI, June 14, 2019 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone) announced today dosing of the first patient in their Phase II global clinical trials (RSJ10101 and RSJ10201) of SHR0302 in patients with Ulcerative Colitis and Crohn's disease respectively. The Phase II studies ...
2019-06-14 20:30
2048
First Uzbekistani Company in Hong Kong to bring Chinese Medicine Business along "The Belt and Road"
HONG KONG, June 14, 2019 /PRNewswire/ -- On June 13, "The Belt and Road" International Cocktail Reception of Chinese Medicine Innovation and Cooperation was held inHong Kong by Yilin Bagu Group JV LLC. The event was attended by the delegation of H.E.Bakhtiyor Saidov, Ambassador of Uzbekistan i...
2019-06-14 12:48
8074
China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Lefamulin
- Chinese registrational clinical trial for lefamulin to begin in 2H 2019 BEIJING and SHANGHAI, June 14, 2019 /PRNewswire/ -- Sinovant Sciences today announced that its Clinical Trial Application (CTA) for lefamulin has been accepted by the Center for Drug Evaluation at the China National Medica...
2019-06-14 09:00
5863
111 Signs Strategic Partnership Agreement with Tong Ren Tang Technologies to Advance "Internet + Healthcare"
SHANGHAI, June 13, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has signed a strategic partnership agreement with Tong Ren Tang Technologies Co., Ltd. ("Tong Ren Tang Technologies") (1666.HK),...
2019-06-14 01:45
11674
Inaugural Global Health Forum of Boao Forum for Asia Held In Qingdao
QINGDAO, China, June 13, 2019 /PRNewswire/ -- The inaugural Global Health Forum (GHF) of Boao Forum forAsia (BFA) was held in Qingdao, China, from June 10 to June 12. Aimed at gathering global consensus on healthcare, pooling wisdom and resources in the medical industry and public health field, a...
2019-06-13 21:34
6130
New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting
Data Presentation & Lunch Symposium at TVT2019 Structural Heart Summit CHICAGO, June 13, 2019 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, presented data at the TVT2019 S...
2019-06-13 21:10
5807
Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference
Avalon GloboCare to Unveil the Launch of its Exosome Product Commercialization Plan at the Second Aesthetic Industry Conference, the Largest Aesthetics Conference Across Asia Yu Zhou, M.D., Ph.D., Co-CEO of Avalon's subsidiary GenExosome Technologies to provide keynote address FREEHOLD, New Jer...
2019-06-13 20:00
9587
Lumosa to Initiate Phase 2 Human Clinical Trial in the US and Taiwan for Its LT3001, A Novel Drug for the Treatment of Acute Ischemic Stroke
TAIPEI, , June 13, 2019 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; code: 6535.TWO) announced that the company is ready to commence the Phase 2 proof of concept (PoC) study for its LT3001, a novel drug for the treatment of acute ischemic stroke (AIS) that showed good safety, tolerability and ...
2019-06-13 20:00
4417
Fairmont Hotels & Resorts Maximizes its Global Occupancy and Welcomes Over 2 Million Well-Travelled Honeybees at its Properties Worldwide
-Fairmont Bee Sustainable launches new digital platform featuring live hive monitoring and in-depth honey analysis to increase awareness of global bee health- PARIS, June 13, 2019 /PRNewswire/ -- To celebrate Pollinator Month, Fairmont Hotels & Resorts, a pioneer of responsible tourism and sou...
2019-06-13 19:27
6213
Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer
* The partnership will leverage Tessa Therapeutics' global operational capabilities and cell therapy platform technologies to target prevalent cancers inChina * The joint venture will be the sole licensee of Tessa Therapeutics' cell therapies for research, development and commercialization in...
2019-06-13 07:15
2368
ISTH President Claire McLintock Receives Officer of the New Zealand Order of Merit on Queen's Birthday Honours List
Award Underscores McLintock's Service to the Fields of Haematology & Obstetrics CHAPEL HILL, North Carolina, June 13, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) today announced that ISTH President Claire McLintock, MD, has received the award of Officer of t...
2019-06-13 02:00
2012
CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA
KFAR SABA, Israel, June 12, 2019 /PRNewswire/ -- CartiHeal, developer of the Agili-C™ implant for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, successfully enrolled the 200th patient in the Agili-C™ IDE pivotal clinical study. Surgery was performed byScott ...
2019-06-12 20:38
2748
AlpVision to Offer the First Online Biological Neural Networks (BNN) Servers Subscription Services for Artificial Intelligence Researchers
VEVEY, Switzerland, June 12, 2019 /PRNewswire/ -- AlpVision SA, a pioneering information and communication technology company and a global leader in advanced signal processing applications, announces at the AI summit inLondon the release plan of bioserver.net, a new cloud computing service based ...
2019-06-12 15:00
2702
Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial
SAN FRANCISCO, June 12, 2019 /PRNewswire/ -- Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The p...
2019-06-12 02:45
2625
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging
CHICAGO and MELBOURNE, Australia, June 12, 2019 /PRNewswire/ -- Amcor today announces the successful completion of its acquisition of Bemis Company Inc., effective11 June 2019. The combined company will now operate as Amcor plc (Amcor), trading on the New York Stock Exchange under the ticker symb...
2019-06-12 02:26
3111
Vitamin World Attends Nutrition 2019 and Supports Research and Development in Bioactivity
BALTIMORE, Md., June 11, 2019 /PRNewswire/ -- From June 8-11, Vitamin World, a leading specialty brand for health products inthe United States, was proud to support Nutrition 2019, the annual flagship meeting organized by the American Society for Nutrition (ASN) and the premier global event focus...
2019-06-11 21:52
2357
Amcor Completes Acquisition of Bemis, Creating the Global Leader in Consumer Packaging
CHICAGO and MELBOURNE, Australia, June 11, 2019 /PRNewswire/ -- Amcor today announces the successful completion of its acquisition of Bemis Company Inc., effective11 June 2019. The combined company will now operate as Amcor plc (Amcor), trading on the New York Stock Exchange under the ticker symb...
2019-06-11 21:46
3243
Centinel Spine Announces Partnership with Tiger Woods
NEW YORK, June 11, 2019 /PRNewswire/ -- Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced an important partnership with one of the most winning professional athletes of all time, Tiger Woods. This partnership brings together ...
2019-06-11 21:12
3776
Zeus Expands Portfolio with New Polyimide Family of Products
Products Include PI Tubing, PI Coated Wire, PI Glide™ Tubing, and PI Glide™ Coated Wire ORANGEBURG, South Carolina, June 11, 2019 /PRNewswire/ -- Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, has announced the introduction of a newpol...
2019-06-11 20:00
3227
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results
HONG KONG, June 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2019 onTuesday, June 18, 2019, after the market close. The Company will host a conference call...
2019-06-11 19:00
13441
Week's Top Stories
Most Reposted
Getac Announces World's First AI-Ready Rugged Laptop
[Picked up by 308 media titles]
2024-05-29 08:00
Aetina Showcases Next-Gen Edge AI Solutions at COMPUTEX 2024
[Picked up by 303 media titles]
2024-05-30 15:00China accelerates construction of intelligent ports
[Picked up by 284 media titles]
2024-05-27 09:00Meiyume Debuts at Cosmoprof CBE Asean Bangkok: Pioneering the Future of Beauty Innovation with Sustainability and Smart Technology
[Picked up by 284 media titles]
2024-05-28 14:00
RF Acquisition Corp II Announces Pricing of $100 Million Initial Public Offering
[Picked up by 274 media titles]
2024-05-29 14:21Most Read
Getac Announces World's First AI-Ready Rugged Laptop
2024-05-29 08:00
9035
RF Acquisition Corp II Announces Pricing of $100 Million Initial Public Offering
2024-05-29 14:21
7454
China accelerates construction of intelligent ports
2024-05-27 09:00
7289
Aetina Showcases Next-Gen Edge AI Solutions at COMPUTEX 2024
2024-05-30 15:00
6442
